APA (7th ed.) Citation

Gkioka, A. I., Repousis, P., Rougkala, N., Asmanis, E., Bartzi, V., Dimou, M., . . . Kyrtsonis, M. (2019). Lenalidomide (Len) Refractory MM Patients' Outcomes. Clinical lymphoma, myeloma & leukemia, 19, e160. https://doi.org/10.1016/j.clml.2019.09.268

Chicago Style (17th ed.) Citation

Gkioka, Annita Ioanna, et al. "Lenalidomide (Len) Refractory MM Patients' Outcomes." Clinical Lymphoma, Myeloma & Leukemia 19 (2019): e160. https://doi.org/10.1016/j.clml.2019.09.268.

MLA (9th ed.) Citation

Gkioka, Annita Ioanna, et al. "Lenalidomide (Len) Refractory MM Patients' Outcomes." Clinical Lymphoma, Myeloma & Leukemia, vol. 19, 2019, p. e160, https://doi.org/10.1016/j.clml.2019.09.268.